Cervical Cancer,Gynecologic Cancer HRQoL in Pembrolizumab-Based Treatment for Cervical Cancer Jun 23, 2023
Gynecologic Cancer,Ovarian Cancer Efficacy of Chemotherapy in BRCA1/2-Mutated Recurrent Epithelial Ovarian Cancer: SOLO2 Phase 3 Trial Apr 17, 2023
Gynecologic Cancer,Ovarian Cancer Patient Evaluation of Atezolizumab Added to Standard Treatment of PSROC Mar 28, 2023
Gynecologic Cancer,Ovarian Cancer Rucaparib as Second-Line Therapy in Advanced Ovarian Cancer: Efficacy and Safety Mar 28, 2023
Gynecologic Cancer,Ovarian Cancer Pros in the Mirasol and Forward I Trial on the Effect of MIRV in the Treatment of PROC Mar 28, 2023
Gynecologic Cancer,Ovarian Cancer Olaparib vs. Non-Platinum Chemotherapy for PSROC with BRCA1/2 Mutations Mar 28, 2023
Gynecologic Cancer,Ovarian Cancer Maintenance Olaparib in PSROC: Safety and Efficacy Regardless of BRCA Status Mar 28, 2023
Gynecologic Cancer,Ovarian Cancer Viability of Rucaparib for Recurring Ovarian Cancer: A Study Mar 28, 2023